Young Nam Lee (Young N Lee)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Computed Tomography

Rheumatoid Arthritis

Diffuse Large B Cell Lymphoma

Top Venues

Clinical drug investigation

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Mark J Bishton, Gilles Salles, Camille Golfier, Wolfgang Knauf, Monica Bocchia, Deborah Turner, Borhane Slama, Jatinder Harchowal, Scott Marshall, Alberto Bosi, Juan José Bargay Lleonart, Manfred Welslau, SooKyoung Kim, Young Nam Lee, Pier Luigi Luigi Zinzani, Kamel Laribi
Real-world clinical effectiveness and safety of CT-P10 in patients with diffuse large B-cell lymphoma: An observational study in Europe. EJHaem 4 (1) (2022)
Mark J Bishton, Gilles Salles, Camille Golfier, Wolfgang Knauf, Monica Bocchia, Deborah Turner, Borhane Slama, Jatinder Harchowal, Scott Marshall, Alberto Bosi, Juan José Bargay Lleonart, Manfred Welslau, SooKyoung Kim, Young Nam Lee, Pier Luigi Luigi Zinzani, Kamel Laribi
Real-world clinical effectiveness and safety of CT-P10 in patients with diffuse large B-cell lymphoma: An observational study in Europe. EJHaem 4 (1) (2022)
Wook-Young Baek, Eunyoung Lee, Sun-Kyung Lee, Yong-Beom Park, Young Nam Lee, Hee Jung Kang, Tae-Jong Kim
Retention Rate and Safety of Biosimilar CT-P13 in Rheumatoid Arthritis: Data from the Korean College of Rheumatology Biologics Registry. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 34 (1) (2020)
Tae Hwan Kim, Shin-Seok Lee, Won Park, Yeong-Wook Song, Chang-Hee Suh, SooKyoung Kim, Young Nam Lee, Dae Hyun Yoo
A 5-year Retrospective Analysis of Drug Survival, Safety, and Effectiveness of the Infliximab Biosimilar CT-P13 in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis. Clinical drug investigation 40 (6) (2020)